Irinotecan Hydrochloride (Sandoz Inc)
Welcome to the PulseAid listing for the Irinotecan Hydrochloride drug offered from Sandoz Inc. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Irinotecan Hydrochloride |
| SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-11-30 |
| END MARKETING DATE: | 0000-00-00 |
Irinotecan Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irinotecan Hydrochloride from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2009-11-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66758-048_4abb4315-bcd7-4055-aea4-2496bbb871f1 |
| PRODUCT NDC: | 66758-048 |
| APPLICATION NUMBER: | ANDA090137 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
